InsiderFlow

MDGL

Madrigal Pharmaceuticals, Inc.$423.25-4.00 (-0.94%)
Prev Close$427.39·MCap$9.93B·P/E—·Vol275.3K·Yield—
▲

Buys (12M)

1

$35.02M

▼

Sells (12M)

25

$55.85M

◆

Net Activity

Net Seller

$20.83M

●

Active Insiders

9

last 12 mo

Over the past 12 months, insider activity at Madrigal Pharmaceuticals, Inc. (MDGL) has been mixed between buying and selling, with 1 insider purchase totaling $35.02M and 25 insider sales totaling $55.85M. The most recent insider transaction was by Kelley Shannon T (officer: General Counsel), who sold $430.8K worth of shares on Nov 6, 2026. Madrigal Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $9.93B.

MDGL Insider Trading Activity

DateInsiderTypeValue
Nov 6, 2026 Kelley Shannon TSell$430.8K
Nov 6, 2026 BAKER BROS. ADVISORS LPBuy$35.02M
Sep 11, 2026 Sibold William JohnSell$6.24M
Aug 20, 2026 Kelley Shannon TSell$341.9K
Jul 20, 2026 Sibold William JohnSell$1.37M
Jun 1, 2026 Soergel DavidSell$516.6K
May 22, 2026 Levy Richard SSell$2.91M
May 18, 2026 Soergel DavidSell$435.4K
Mar 6, 2026 Dier MardiSell$680.1K
Mar 6, 2026 Huntsman CaroleSell$181.0K
Mar 6, 2026 Kelley Shannon TSell$155.5K
Mar 6, 2026 Sibold William JohnSell$718.3K
Mar 6, 2026 Taub RebeccaSell$212.1K
Mar 2, 2026 Dier MardiSell$505.4K
Jan 26, 2026 Huntsman CaroleSell$449.3K
Jan 26, 2026 Sibold William JohnSell$776.5K
Jan 26, 2026 Taub RebeccaSell$318.6K
Jan 20, 2026 Kelley Shannon TSell$344.2K
Jan 20, 2026 Taub RebeccaSell$1.10M
Jan 13, 2026 FRIEDMAN PAUL ASell$12.77M
Jan 13, 2026 Taub RebeccaSell$8.95M
Jan 9, 2026 FRIEDMAN PAUL ASell$154.3K
Jan 9, 2026 Taub RebeccaSell$132.1K
Dec 10, 2025 FRIEDMAN PAUL ASell$13.69M
Dec 3, 2025 Sibold William JohnSell$1.38M
Nov 21, 2025 Huntsman CaroleSell$1.08M
Nov 5, 2025 BATE KENNETHSell$8.03M
Aug 21, 2025 Sibold William JohnSell$3.05M
Aug 15, 2025 BATE KENNETHSell$3.65M
Aug 11, 2025 FRIEDMAN PAUL ASell$16.63M
Jul 18, 2025 FRIEDMAN PAUL ASell$490.0K
Jul 16, 2025 FRIEDMAN PAUL ASell$10.20M
Mar 10, 2025 Dier MardiSell$83.3K
Mar 3, 2025 Huntsman CaroleSell$597.8K
Feb 27, 2025 BATE KENNETHSell$7.13M
Jan 27, 2025 Huntsman CaroleSell$116.3K
Jan 27, 2025 Sibold William JohnSell$531.0K
Jan 27, 2025 Taub RebeccaSell$217.2K
Jan 27, 2025 Waltermire Robert E.Sell$34.5K
Jan 17, 2025 Kelley Shannon TSell$75.7K
Jan 17, 2025 Taub RebeccaSell$461.8K
Jan 17, 2025 Waltermire Robert E.Sell$120.8K
Dec 5, 2024 CRAVES FRED BSell$1.14M
Nov 27, 2024 CRAVES FRED BSell$1.19M
Nov 22, 2024 Huntsman CaroleSell$218.0K
Nov 8, 2024 Levy Richard SSell$1.75M
Nov 5, 2024 Levy Richard SSell$1.50M
Sep 11, 2024 Sibold William JohnSell$1.55M
Jun 18, 2024 Waltermire Robert E.Sell$532.0K
Jun 14, 2024 Waltermire Robert E.Sell$570.0K
1 / 2

MDGL Insider Buying Activity

The following table shows recent insider purchases of Madrigal Pharmaceuticals, Inc. (MDGL) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 6, 2026 BAKER BROS. ADVISORS LPBuy$35.02M

MDGL Insider Selling Activity

The following table shows recent insider sales of Madrigal Pharmaceuticals, Inc. (MDGL) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 6, 2026 Kelley Shannon TSell$430.8K
Sep 11, 2026 Sibold William JohnSell$6.24M
Aug 20, 2026 Kelley Shannon TSell$341.9K
Jul 20, 2026 Sibold William JohnSell$1.37M
Jun 1, 2026 Soergel DavidSell$516.6K
May 22, 2026 Levy Richard SSell$2.91M
May 18, 2026 Soergel DavidSell$435.4K
Mar 6, 2026 Dier MardiSell$680.1K
Mar 6, 2026 Huntsman CaroleSell$181.0K
Mar 6, 2026 Kelley Shannon TSell$155.5K
Mar 6, 2026 Sibold William JohnSell$718.3K
Mar 6, 2026 Taub RebeccaSell$212.1K
Mar 2, 2026 Dier MardiSell$505.4K
Jan 26, 2026 Huntsman CaroleSell$449.3K
Jan 26, 2026 Sibold William JohnSell$776.5K
Jan 26, 2026 Taub RebeccaSell$318.6K
Jan 20, 2026 Kelley Shannon TSell$344.2K
Jan 20, 2026 Taub RebeccaSell$1.10M
Jan 13, 2026 FRIEDMAN PAUL ASell$12.77M
Jan 13, 2026 Taub RebeccaSell$8.95M
Jan 9, 2026 FRIEDMAN PAUL ASell$154.3K
Jan 9, 2026 Taub RebeccaSell$132.1K
Dec 10, 2025 FRIEDMAN PAUL ASell$13.69M
Dec 3, 2025 Sibold William JohnSell$1.38M
Nov 21, 2025 Huntsman CaroleSell$1.08M
Nov 5, 2025 BATE KENNETHSell$8.03M
Aug 21, 2025 Sibold William JohnSell$3.05M
Aug 15, 2025 BATE KENNETHSell$3.65M
Aug 11, 2025 FRIEDMAN PAUL ASell$16.63M
Jul 18, 2025 FRIEDMAN PAUL ASell$490.0K
Jul 16, 2025 FRIEDMAN PAUL ASell$10.20M
Mar 10, 2025 Dier MardiSell$83.3K
Mar 3, 2025 Huntsman CaroleSell$597.8K
Feb 27, 2025 BATE KENNETHSell$7.13M
Jan 27, 2025 Huntsman CaroleSell$116.3K
Jan 27, 2025 Sibold William JohnSell$531.0K
Jan 27, 2025 Taub RebeccaSell$217.2K
Jan 27, 2025 Waltermire Robert E.Sell$34.5K
Jan 17, 2025 Kelley Shannon TSell$75.7K
Jan 17, 2025 Taub RebeccaSell$461.8K
Jan 17, 2025 Waltermire Robert E.Sell$120.8K
Dec 5, 2024 CRAVES FRED BSell$1.14M
Nov 27, 2024 CRAVES FRED BSell$1.19M
Nov 22, 2024 Huntsman CaroleSell$218.0K
Nov 8, 2024 Levy Richard SSell$1.75M
Nov 5, 2024 Levy Richard SSell$1.50M
Sep 11, 2024 Sibold William JohnSell$1.55M
Jun 18, 2024 Waltermire Robert E.Sell$532.0K
Jun 14, 2024 Waltermire Robert E.Sell$570.0K

MDGL Insiders

BAKER BROS. ADVISORS LP

Director

Bought $637.77M
6 tradesLast: Nov 6, 2026
Kelley Shannon T

officer: General Counsel

Sold $1.35M
5 tradesLast: Nov 6, 2026
Sibold William John

President and CEO

Sold $15.61M
8 tradesLast: Sep 11, 2026
Soergel David

officer: Chief Medical Officer

Sold $952.0K
2 tradesLast: Jun 1, 2026
Levy Richard S

Director

Sold $15.59M
5 tradesLast: May 22, 2026
Huntsman Carole

officer: Chief Commercial Officer

Sold $2.65M
6 tradesLast: Mar 6, 2026
Dier Mardi

SVP and CFO

Sold $1.27M
3 tradesLast: Mar 6, 2026
Taub Rebecca

Pres., R&D, and CMO

Sold $30.08M
9 tradesLast: Mar 6, 2026
FRIEDMAN PAUL A

Director

Sold $78.39M
8 tradesLast: Jan 13, 2026
BATE KENNETH

Director

Sold $27.02M
4 tradesLast: Nov 5, 2025
Waltermire Robert E.

Senior VP, Chief Pharma Dev.

Sold $6.02M
8 tradesLast: Jan 27, 2025
CRAVES FRED B

Director

Sold $7.11M
3 tradesLast: Dec 5, 2024
Daly James M

Director

Sold $8.15M
1 tradesLast: Apr 3, 2024
Lynch Brian Joseph

SVP and General Counsel

Sold $7.63M
4 tradesLast: Dec 6, 2023
Sukhija Remy

Chief Commercial Officer

Sold $8.22M
1 tradesLast: Dec 28, 2022